TABLE 2.
Linear regression analysis of heterologous versus homologous Gag peptide pool responses in HIV-1 and HIV-2 patientsa
Gag peptide pool pair | Linear regression
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
All patients
|
CD4-matched patients
|
|||||||||||
HIV-1 infected (n = 17)
|
HIV-2 infected (n = 17)
|
HIV-1 infected (n = 7)
|
HIV-2 infected (n = 7)
|
|||||||||
B | R2 | P | B | R2 | P | B | R2 | P | B | R2 | P | |
1 | 1.06 | 0.91 | <0.001 | 0.23 | 0.30 | 0.018 | 0.36 | 0.39 | 0.100 | 0.08 | 0.05 | 0.580 |
2 | 0.21 | 0.28 | 0.024 | 0.13 | 0.15 | 0.107 | 0.74 | 0.58 | 0.028 | 0.08 | 0.07 | 0.519 |
3 | 1.29 | 0.81 | <0.001 | 0.15 | 0.08 | 0.717 | 1.08 | 0.85 | 0.001 | 0.01 | 0.00 | 0.918 |
4 | 0.52 | 0.62 | <0.001 | 0.07 | 0.06 | 0.315 | 0.67 | 0.85 | 0.001 | 0.04 | 0.02 | 0.757 |
5 | 0.17 | 0.30 | 0.018 | 0.18 | 0.24 | 0.039 | 0.18 | 0.26 | 0.198 | 0.18 | 0.13 | 0.346 |
6 | 0.25 | 0.30 | 0.019 | 0.16 | 0.34 | 0.011 | 0.23 | 0.33 | 0.140 | 0.42 | 0.71 | 0.009 |
7 | 0.93 | 0.62 | <0.001 | 0.04 | 0.06 | 0.321 | 0.71 | 0.83 | 0.002 | 0.03 | 0.06 | 0.568 |
8 | 0.07 | 0.27 | 0.028 | 1.20 | 0.33 | 0.012 | 0.08 | 0.52 | 0.043 | 1.78 | 0.47 | 0.059 |
9 | 0.15 | 0.42 | 0.004 | 0.06 | 0.19 | 0.067 | 0.56 | 0.42 | 0.085 | 0.04 | 0.27 | 0.185 |
10 | 0.12 | 0.46 | 0.002 | 0.06 | 0.05 | 0.363 | 0.42 | 0.83 | 0.002 | 0.03 | 0.03 | 0.669 |
11 | 1.23 | 0.73 | <0.001 | 0.05 | 0.10 | 0.213 | 1.36 | 0.93 | <0.001 | 0.02 | 0.15 | 0.349 |
12 | 0.65 | 0.84 | <0.001 | 0.46 | 0.30 | 0.019 | 0.92 | 0.87 | 0.001 | 0.66 | 0.40 | 0.095 |
Data are calculated with linear regression analysis through the origin. B, slope of the regression line; R2, proportion of the variability in the dependent variable about the origin explained by regression; P, level of significance. Regressions with P < 0.05 are in boldface.